Mobile Apps Designed for Patients With Polycystic Ovary Syndrome: Content Analysis Using the Mobile App Rating Scale
Journal of Medical Internet Research · 17.06.2025 · 27 · e71118-e71118
DOI: 10.2196/71118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 17.06.2025. Verfasst von Zahra Arabkermani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Mobile Applications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Digital health interventions, especially mobile apps, have become instrumental in helping women at risk of polycystic ovary syndrome (PCOS), increasing their understanding of the condition, improving self-care, and fostering empowerment. However, their rapid proliferation has brought about significant challenges regarding quality assessment and evidence-based determination. Therefore, establishing reliable quality assessment methods is essential to assist patients with PCOS in identifying effective and trustworthy mobile health tools.
Objective
This study was designed to assess the content and quality of mobile apps developed for patients with PCOS using the Mobile App Rating Scale (MARS) to provide insights into their strengths, limitations, and areas needing improvement.
Methods
In this descriptive-analytical study conducted in June 2024, a comprehensive search was performed to identify English and Persian mobile apps related to PCOS through the Café Bazaar and Google Play Store platforms, using both direct search methods and auxiliary tools such as AppAgg and AppBrain. Two trained reviewers (AR and NN) independently reviewed the apps using the MARS tool. The interrater reliability was measured using the intraclass correlation coefficient test. The quality of each app was scored across 4 dimensions: engagement, functionality, aesthetics, and information quality.
Results
Of the initial 199 apps identified, 15 met the inclusion criteria after screening and updates. The interrater agreement rate was 85%, which is considered acceptable. The apps’ overall quality was sufficient, as assessed using the MARS, with a mean score of 3.6 (SD 0.52) of 5. Functionality and aesthetics emerged as the highest-scoring dimensions, highlighting user-friendliness and visual appeal (n=10). In contrast, engagement following information quality received the lowest average score, indicating limited interactivity and gaps in providing evidence-based information. The Ask PCOS app achieved the highest overall score, performing exceptionally well in subjective quality (4.75) and app-specific quality (4.33), reflecting its strong capacity to positively impact users’ knowledge, attitudes, and behaviors related to PCOS. Uvi Health and Ask PCOS scored highest in engagement (4.2), while PCOS & PCOD Diet & Remedies led in functionality (5), and Uvi Health topped aesthetics (5).
Conclusions
The findings revealed that even though many available PCOS-related apps demonstrate strengths in technical performance and design, critical limitations persist regarding user engagement and the credibility of the information provided. The predominance of commercially affiliated apps without academic or clinical oversight was identified as a key contributing factor to these shortcomings. These results underscore the need for future app development to incorporate more user-engaging features, reliable evidence-based content, and personalization strategies to enhance user engagement and support effective PCOS self-management. Addressing these limitations and leveraging the capabilities of existing mobile devices are essential steps toward improving the overall quality and impact of mobile health interventions for individuals with PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
- Student Research Committee, Mazandaran University of Medical Sciences, Farah Abad Street, 1454, Sari, 48175, Iran, 09369118477.
- Management Information Systems, College of Business Administration, Gulf University for Science and Technology, Mishref, Kuwait.
- Department of Software Engineering, Faculty of Engineering and Natural Sciences, Bandirma Onyedi Eylul University, Balıkesir, Turkey.
- Department of Computer Science and Engineering, College of Informatics, Korea University, Seoul, Republic of Korea.
Zitieren
APA
Arabkermani, Z., Barzegari, S., Rouhani, A., Nahavandi, N., Gibreel, O., & Arpaci, I. (2025). Mobile Apps Designed for Patients With Polycystic Ovary Syndrome: Content Analysis Using the Mobile App Rating Scale. Journal of Medical Internet Research, 27, e71118-e71118. https://doi.org/10.2196/71118
Vancouver
Arabkermani Z, Barzegari S, Rouhani A, Nahavandi N, Gibreel O, Arpaci I. Mobile Apps Designed for Patients With Polycystic Ovary Syndrome: Content Analysis Using the Mobile App Rating Scale. Journal of Medical Internet Research. 2025;27:e71118-e71118. doi:10.2196/71118
BibTeX
@article{Arabkermani2025,
author = {Arabkermani, Zahra and Barzegari, Saeed and Rouhani, Atefeh and Nahavandi, Nilofar and Gibreel, Omer and Arpaci, Ibrahim},
title = {Mobile Apps Designed for Patients With Polycystic Ovary Syndrome: Content Analysis Using the Mobile App Rating Scale},
journal = {Journal of Medical Internet Research},
year = {2025},
volume = {27},
pages = {e71118--e71118},
doi = {10.2196/71118}
}
EUVIMED